Top Market Data Stories


Comment & Analysis »

GlobalData Healthcare

Trulance sNDA submission for IBS-C: a step forward for Synergy Pharmaceuticals

On March 27, 2017, Synergy Pharmaceuticals submitted a supplemental New Drug Application (sNDA) for its Trulance (plecanatide) for the treatment of adults with constipation-predominant...

Trulance sNDA submission for IBS-C: a step forward for Synergy Pharmaceuticals
GlobalData Healthcare

Rethinking future treatment options for sepsis: from immunosuppressive to immunostimulating drugs

Rethinking future treatment options for sepsis: from immunosuppressive to immunostimulating drugs
GlobalData Healthcare

FOURIER outcomes data highlights the importance of value in drug development

FOURIER outcomes data highlights the importance of value in drug development
GlobalData Healthcare

Unmet needs in the liver cancer market mean it’s full of potential

Unmet needs in the liver cancer market mean it’s full of potential
GlobalData Healthcare

First-in-class opioid analgesic NKTR-181 boasts strong Phase III results

First-in-class opioid analgesic NKTR-181 boasts strong Phase III results

Company Releases »

Benefits of Trehalose

Pfanstiehl
Benefits of Trehalose

Characterisation Information of Critical Excipients for Sourcing Critical Raw Materials

Pfanstiehl
Characterisation Information of Critical Excipients for Sourcing Critical Raw Materials

Paradigm Shift Regarding API and Formulation Components

Pfanstiehl Paradigm Shift Regarding API and Formulation Components

Validated Metal Analysis

Pfanstiehl
Validated Metal Analysis

Customized Project Management and Leadership Development Courses

Successful Strategies International Customized Project Management and Leadership Development Courses

Market Data Insights »

Companies »